Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study offers hope for equine pregnancy loss
Dr Mandi de Mestre, a reader in reproductive immunology at the RVC.

Findings will allow researchers to develop new diagnostic tests.

One of the most common causes of equine pregnancy loss has been highlighted in a pioneering study led by researchers at the RVC.

The study, published in the journal Scientific Reports, identifies that a chromosomal defect is a key reason why a significant number of equine pregnancies fail within the first two months of development.

Researchers say the discovery could lead to the development of new diagnostic tests, offering hope to the thousands of owners of breeding mares that suffer this condition.

“Early pregnancy loss remains a very frustrating condition for clinicians to treat as the underlying cause is unknown in around 80 per cent of cases,” commented Dr Mandi de Mestre, a reader in reproductive immunology at the RVC.

“A diagnostic test would allow them to make informed decisions on treatment strategies and to advise on whether they should invest in further attempts to breed their mare benefiting both horses and their breeders alike in the future.”

Because the underlying cause behind equine pregnancy loss is often unknown, it is notoriously difficult for veterinary surgeons to manage. In this study, researchers determined 'aneuploid pregnancies' as the major factor for the condition, similar to Down’s Syndrome screened for in human pregnancy

Researchers collaborated with seven different veterinary practices to gain access to samples from across the UK and Ireland and found that around 20 per cent of the pregnancies lost were aneuploid.  To confirm the results, RVC PhD student Charlotte Shilton applied three different genetic approaches.

Scientists are now investigating the underlying cause of these aneuploid pregnancies, with early data suggesting it is most commonly introduced via the egg or sperm. Until now, chromosomal defects such as aneuploidy have only been reported as rare in young horses with developmental disorders.

Researchers say the study shows why the condition is so rare in horses and highlights the need to reconsider this condition both in pregnancy loss but also for early developmental disorders. 

Image (C) RVC.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.